Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Non-Current Assets (2021 - 2025)

PAVmed has reported Non-Current Assets over the past 5 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $3.0 million for Q4 2025, down 46.52% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (down 46.52% YoY), and the annual figure for FY2025 was $3.0 million, down 46.52%.
  • Non-Current Assets for Q4 2025 was $3.0 million at PAVmed, down from $3.4 million in the prior quarter.
  • Over the last five years, Non-Current Assets for PAVM hit a ceiling of $13.3 million in Q1 2022 and a floor of $861000.0 in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $6.6 million (2024), compared with a mean of $6.9 million.
  • Biggest five-year swings in Non-Current Assets: surged 1448.43% in 2022 and later plummeted 47.46% in 2025.
  • PAVmed's Non-Current Assets stood at $4.3 million in 2021, then surged by 131.71% to $10.1 million in 2022, then decreased by 14.25% to $8.6 million in 2023, then tumbled by 35.43% to $5.6 million in 2024, then plummeted by 46.52% to $3.0 million in 2025.
  • The last three reported values for Non-Current Assets were $3.0 million (Q4 2025), $3.4 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.